ArticleCancer research2007

Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.

Bing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.